Paul Sowyrda is an accomplished executive and inventor with over 30 years of experience in the pharmaceutical and biotechnology sectors. He co-founded Novellus, Inc. and served as its Executive Vice President until its acquisition by Brooklyn ImmunoTherapeutics in 2021. Paul has held key leadership roles, including Vice President of Drug Development at CIBA, Vice President of Development and Marketing at Dusa Pharmaceuticals, and Vice President of Product Development for Chiron Corporation.